Fundraising Fox

Latigo Biotherapeutics

Thousand Oaks, US · Delaware corporation · 4 known investors

Biotech

Founders & leadership

NF
Nima FarzanExecutive Officer, Director
TL
Tim LugoExecutive Officer
BS
Beth SeidenbergDirector
JT
Jim TananbaumDirector
DP
Deborah PalestrantDirector
KR
Kevin RaidyDirector
NS
Nancy StaglianoDirector
TW
Tim WalbertDirector

Investors · 4

Foresite CapitalLarkspur
Kern Capital, LLCLarkspur · $5M – $15Mvia Jay Kern · inferred
5AM VenturesreportedBoston · $100K – $4Mvia Deborah Palestrant · board
Westlake Village BioPartnersreportedLos Angeles · $100K – $5Mvia Beth Seidenberg · board

Reported raises · per SEC filings

Form D private placements
▶$50MraisedFeb 2025 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nancy StaglianoDirector
  • Beth SeidenbergDirector
  • Nima FarzanExecutive Officer, Director
  • Jim TananbaumDirector
  • Deborah PalestrantDirector
  • Kevin RaidyDirector
  • Tim LugoExecutive Officer
  • Tim WalbertDirector
Offering amount
$150M
Amount sold
$50M
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.